Evaluation of a novel pre-filled syringe for self-administration of certolizumab pegol results from a syringe usability study

被引：0
|
作者：
Schiff, M. [1 ]
Sheikhzadeh, A. [2 ]
Formosa, D. [3 ]
Domanska, B. [4 ]
Morgan, D. [4 ]
机构：
[1] Univ Colorado, Sch Med, Denver, CO USA
[2] NYU, NYU Hosp Joint Dis, New York, NY 10003 USA
[3] Smart Design, New York, NY USA
[4] UCB Celltech, Slough, Berks, England
来源：
INFLAMMATORY BOWEL DISEASES | 2009年 / 15卷 / 12期
关键词：
D O I：
10.1097/00054725-200912002-00120
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S40 / S40
页数：1
相关论文
共 50 条
  • [31] Treatment switch from aflibercept to ranibizumab pre-filled syringe in Canadian nAMD and DME patients in a real-world setting: The PRECISE study
    Somani, Sohel
    Giunta, Michel
    Kalevar, Ananda
    Tuli, Raman
    Caron, Louis
    Trottier, Pierre
    Hussein, Shamiza
    Adiguzel, Eser
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2020, 61 (07)
  • [32] A novel UPLC-PDA isocratic method for the quantification fulvestrant in oil-based pre-filled syringe injection matrix formulations
    Thirupathi Dongala
    Ashok Kumar Palakurthi
    Yashodharani Vytla
    Naresh Kumar Katari
    Journal of Analytical Science and Technology, 10
  • [33] ESTIMATING THE COST IMPACT OF SWITCHING FROM A VIAL TO A PRE-FILLED SYRINGE MODE OF ADMINISTRATION FOR THE DTAA-IPV-HIB '5-IN-1' VACCINE IN INFANTS
    Kumar, G.
    Padhiar, A.
    Carroll, S.
    Woods, B.
    Shread, K.
    VALUE IN HEALTH, 2013, 16 (07) : A345 - A345
  • [34] A RANDOMIZED CROSS-OVER STUDY OF ACCEPTABILITY AND PAIN PERCEPTION COMPARING ARANESP® PRE-FILLED SYRINGE TO ARANESP SURECLICK™ DEVICE
    Chavinga, D.
    Dogra, G.
    Lim, W. H.
    NEPHROLOGY, 2011, 16 : 38 - 38
  • [35] A novel UPLC-PDA isocratic method for the quantification fulvestrant in oil-based pre-filled syringe injection matrix formulations
    Dongala, Thirupathi
    Palakurthi, Ashok Kumar
    Vytla, Yashodharani
    Katari, Naresh Kumar
    JOURNAL OF ANALYTICAL SCIENCE AND TECHNOLOGY, 2019, 10 (1)
  • [36] Patient, nurse, and physician preferences: final results of the CONVENIENCE study evaluating pegfilgrastim prophylaxis via pre-filled syringe or on-body injector in cancer patients
    Michael Metz
    Dieter Semsek
    Gunther Rogmans
    Ulrich Hutzschenreuter
    Thomas Fietz
    Johanna Harde
    Stefan Zacharias
    Carsten Hielscher
    Andreas Lorenz
    Mark-Oliver Zahn
    Dagmar Guth
    Steffen Liebers
    Michael Berghorn
    Sina Grebhardt
    Christiane D. Matillon
    Gerlinde Egerer
    Karin Potthoff
    Supportive Care in Cancer, 2021, 29 : 6633 - 6643
  • [37] Patient, nurse, and physician preferences: final results of the CONVENIENCE study evaluating pegfilgrastim prophylaxis via pre-filled syringe or on-body injector in cancer patients
    Metz, Michael
    Semsek, Dieter
    Rogmans, Gunther
    Hutzschenreuter, Ulrich
    Fietz, Thomas
    Harde, Johanna
    Zacharias, Stefan
    Hielscher, Carsten
    Lorenz, Andreas
    Zahn, Mark-Oliver
    Guth, Dagmar
    Liebers, Steffen
    Berghorn, Michael
    Grebhardt, Sina
    Matillon, Christiane D.
    Egerer, Gerlinde
    Potthoff, Karin
    SUPPORTIVE CARE IN CANCER, 2021, 29 (11) : 6633 - 6643
  • [38] Safety and Usability of Infliximab Administration by Auto-injector (AI) and Pre-filled Syringe (PFS) in Patients with Active Rheumatoid Arthritis (RA): Patient-reported Experience from a Multicenter, Randomized Controlled Pivotal Trial
    Westhovens, Rene
    Yoo, DaeHyun
    Wiland, Piotr
    Zawadzki, Marek
    Ivanova, Delina
    Kasay, Alfredo Berrocal
    Chalouhi, Elias
    Balazs, Eva
    Lee, SangJoon
    Kim, SungHyun
    Suh, JeeHye
    Han, NooRi
    Lee, HoJae
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [39] COMPARISON OF THE BIOAVAILABILITY OF A SINGLE DOSE OF CERTOLIZUMAB PEGOL INJECTED BY PRE-FILLED SYRINGE OR BY ELECTRO-MECHANICAL AUTO-INJECTION E-DEVICE: A PHASE 1, OPEN-LABEL, RANDOMISED, PARALLEL GROUP, SINGLE-CENTRE BIOEQUIVALENCE STUDY
    Oliver, R.
    VanLunen, B.
    Mountian, I.
    Brown, E.
    Tatla, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 961 - 961
  • [40] Patient, nurse and physician preferences: Final results of the CONVENIENCE study evaluating pegfilgrastim prophylaxis via pre-filled syringe or On-body injector (OBI) in cancer patients
    Metz, M.
    Semsek, D.
    Rogmans, G.
    Hutzschenreuter, U.
    Fietz, T.
    Harde, J.
    Zacharias, S.
    Hielscher, C.
    Lorenz, A.
    Zahn, M-O.
    Guth, D.
    Grebhardt, S.
    Fichter, C. D.
    Potthoff, K.
    ANNALS OF ONCOLOGY, 2020, 31 : S1071 - S1071
12345